DCN and central nervous system cancer: Decorin has previously been shown to activate autophagy in endothelial cells, through VEGFR2/AMPKα activation and mTOR inhibition [39, 40], and in breast carcinoma cells [41] and activates autophagy flux in glioma cells [42] and intestinal cells [43].